Healthcare provider profile · identity verified

Darian Leigh Roberts, MD

Family Practice · WELLSBURG, WV · NPI 1649774449

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	155
Lisinopril	Lisinopril	357	109
Omeprazole	Omeprazole	308	87
Levothyroxine Sodium	Levothyroxine Sodium	280	79
Albuterol Sulfate Hfa	Albuterol Sulfate	217	69
Amlodipine Besylate	Amlodipine Besylate	216	71
Gabapentin	Gabapentin	180	56
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	179	68
Montelukast Sodium	Montelukast Sodium	171	49
Metoprolol Succinate	Metoprolol Succinate	160	51
Losartan Potassium	Losartan Potassium	155	44
Rosuvastatin Calcium	Rosuvastatin Calcium	148	41
Famotidine	Famotidine	147	54
Fluticasone Propionate	Fluticasone Propionate	141	59
Pantoprazole Sodium	Pantoprazole Sodium	138	39
Metformin Hcl	Metformin Hcl	135	41
Metoprolol Tartrate	Metoprolol Tartrate	115	38
Eliquis	Apixaban	108	26
Trazodone Hcl	Trazodone Hcl	107	34
Furosemide	Furosemide	99	32
Hydrochlorothiazide	Hydrochlorothiazide	94	31
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	94	24
Duloxetine Hcl	Duloxetine Hcl	87	30
Sertraline Hcl	Sertraline Hcl	84	22
Simvastatin	Simvastatin	80	28
Buspirone Hcl	Buspirone Hcl	75	29
Ozempic	Semaglutide	75	15
Potassium Chloride	Potassium Chloride	74	26
Tizanidine Hcl	Tizanidine Hcl	66	29
Jardiance	Empagliflozin	61	17
Trulicity	Dulaglutide	54	suppressed
Carvedilol	Carvedilol	50	16
Metformin Hcl Er	Metformin Hcl	49	19
Citalopram Hbr	Citalopram Hydrobromide	47	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	14
Mirtazapine	Mirtazapine	47	17
Diclofenac Sodium	Diclofenac Sodium	46	26
Allopurinol	Allopurinol	44	12
Meloxicam	Meloxicam	43	13
Ezetimibe	Ezetimibe	42	14
Lorazepam	Lorazepam	41	16
Pravastatin Sodium	Pravastatin Sodium	40	14
Azelastine Hcl	Azelastine Hcl	38	19
Clopidogrel	Clopidogrel Bisulfate	38	12
Hydralazine Hcl	Hydralazine Hcl	38	13
Alendronate Sodium	Alendronate Sodium	37	13
Bumetanide	Bumetanide	37	12
Nystatin	Nystatin	35	12
Tamsulosin Hcl	Tamsulosin Hcl	35	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Glipizide	Glipizide	34	12
Prednisone	Prednisone	34	23
Valsartan	Valsartan	32	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Estradiol	Estradiol	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Naproxen	Naproxen	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Cephalexin	Cephalexin	16	12
Finasteride	Finasteride	16	suppressed
Ketoconazole	Ketoconazole	16	11
Sucralfate	Sucralfate	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Topiramate	Topiramate	16	suppressed
Torsemide	Torsemide	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Azithromycin	Azithromycin	14	11
Baclofen	Baclofen	14	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Cefdinir	Cefdinir	13	11
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Nystop	Nystatin	13	suppressed
Atenolol	Atenolol	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error